Laura Lee Sandler, Chief Operating Officer at Oruka Therapeutics, Inc. (ORKA), sold 26,000 shares at $28.17 ($742K) on 2026-01-02, disclosed to the SEC on 2026-01-02.
Open-market sale of $742k ORKA by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.17 | 8,748 | $246K | 33.2% |
| 2 | $28.17 | 8,748 | $246K | 33.2% |
| 3 | $29.08 | 3,144 | $91K | 12.3% |
| 4 | $29.08 | 3,144 | $91K | 12.3% |
| 5 | $29.75 | 1,108 | $33K | 4.4% |
| 6 | $29.75 | 1,108 |
| $33K |
| 4.4% |
| Total | $28.52 avg | 26,000 | $742K | 100% |
| Filing → |
| ORKA | SELL | 2026-06-15 | $42K | — | Filing → |
| ORKA | SELL | 2026-05-01 | $319K | — | Filing → |
| ORKA | SELL | 2026-03-17 | $25K | — | Filing → |